Lower Profits 2025, higher later
Patience pays off for long-term investors!
Short-term setbacks open up opportunities!
Reading Time: 1 minute
Novo Nordisk anticipates only 4–10% profit growth in 2025 due to high restructuring costs, compared to the previous forecast of 10–16%. Starting in 2026, annual savings of approximately 8 billion DKK are expected to take effect. Novo Nordisk anticipates only 4–10% profit growth in 2025 due to high restructuring costs, compared to the previous estimate of 10–16%. Starting in 2026, annual savings of about €1.1 billion (approximately DKK 8 billion) are expected to materialize. Under the new CEO Maziar Mike Doustdar, a stronger focus on diabetes...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
